This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TGAN Transphorm (TGAN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Transphorm Stock (NASDAQ:TGAN) 30 days 90 days 365 days Advanced Chart Get Transphorm alerts:Sign Up Key Stats Today's Range$5.10▼$5.1050-Day Range$4.75▼$5.1052-Week Range$1.94▼$5.11VolumeN/AAverage Volume329,669 shsMarket Capitalization$316.00 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewTransphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications. The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.Read More… Receive TGAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Transphorm and its competitors with MarketBeat's FREE daily newsletter. Email Address TGAN Stock News HeadlinesRenesas Completes Acquisition of TransphormJune 20, 2024 | businesswire.comTransphorm Demonstrates a Bidirectional SuperGaN Power Supply with New Reference Design for E-Mobility and Energy/Industrial MarketsJune 11, 2024 | businesswire.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.May 31, 2025 | American Alternative (Ad)St. Charles County Dermatologic Surgery Joins Epiphany DermatologyMay 20, 2024 | businesswire.comTransphorm's SuperGaN at PCIM 2024: Surpassing SiC and e-mode GaN Capabilities in High Power SystemsMay 20, 2024 | businesswire.comTransphorm and Weltrend Semiconductor Release New Integrated GaN System-in-PackagesApril 24, 2024 | businesswire.comURGENT: The M&A Class Action Firm Encourages Shareholders of Transphorm, Inc. to Take Action Before the Merger Vote on April 9, 2024 - TGANMarch 26, 2024 | prnewswire.comTRANSPHORM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Transphorm, Inc. - TGANMarch 13, 2024 | businesswire.comSee More Headlines Company Calendar Today5/31/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Semiconductors & related devices Sub-IndustryElectronic Equipment Current SymbolNASDAQ:TGAN CIK1715768 Webwww.transphormusa.com Phone805-456-1300FaxN/AEmployees110Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.69) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$30.60 million Net Margins-177.91% Pretax Margin-177.91% Return on Equity-149.03% Return on Assets-86.65% Debt Debt-to-Equity RatioN/A Current Ratio1.69 Quick Ratio0.88 Sales & Book Value Annual Sales$18.76 million Price / Sales16.85 Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book15.45Miscellaneous Outstanding Shares61,960,000Free Float60,430,000Market Cap$316.00 million OptionableNot Optionable Beta0.57 Social Links 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:TGAN) was last updated on 5/31/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Transphorm, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Transphorm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TGAN Stock Free TGAN Stock Alerts